Molecular and culture-based bronchoalveolar lavage fluid testing for the diagnosis of Cytomegalovirus pneumonitis

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2015, Pages

  Tan, Susanna K ^a   Burgener, Elizabeth B ^a   Waggoner, Jesse J ^a   Gajurel, Kiran ^a   Gonzalez, Sarah ^a   Chen, Sharon F ^a   Pinsky, Benjamin A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchoalveolar lavage; Cytomegalovirus; Diagnostics; Pneumonitis

Indexed keywords

AMPHOTERICIN B; GENTAMICIN; RITUXIMAB; VANCOMYCIN;

ADULT; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLUENZA A; INFLUENZA B; MAJOR CLINICAL STUDY; MIDDLE AGED; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VIRUS CULTURE;

EID: 85000384247     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv212     Document Type: Article

References (36)

1. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010; 50:1439-47.
2. Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am 2010; 24:319-37.
3. Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96:333-60.
4. Travi G, Pergam SA. Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 2013; 29:200-12.
5. Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-theart management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 2011; 43 (3 Suppl):S1-17.
6. Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant 2004; 4:1219-26.
7. Scaglione S, Hofmeister CC, Stiff P. Evaluation of pulmonary infiltrates in patients after stem cell transplantation. Hematology 2005; 10:469-81.
8. Chellapandian D, Lehrnbecher T, Phillips B, et al. Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol 2015; 33:501-9.
9. Emanuel D, Peppard J, Chehimi J, et al. The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus. Transplant Proc 1987; 19 (6 Suppl 7):132-7.
10. Crawford SW, Bowden RA, Hackman RC, et al. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988; 108:180-5.
11. Erice A, Hertz MI, Snyder LS, et al. Evaluation of centrifugation cultures of bronchoalveolar lavage fluid for the diagnosis of cytomegalovirus pneumonitis. Diagn Microbiol Infect Dis 1988; 10:205-12.
12. Woods GL, Thompson AB, Rennard SL, Linder J. Detection of cytomegalovirus in bronchoalveolar lavage specimens. Spin amplification and staining with a monoclonal antibody to the early nuclear antigen for diagnosis of cytomegalovirus pneumonia. Chest 1990; 98:568-75.
13. Cathomas G, Morris P, Pekle K, et al. Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells. Blood 1993; 81:1909-14.
14. Liesnard C, De Wit L, Motte S, et al. Rapid diagnosis of cytomegalovirus lung infection by DNA amplification in bronchoalveolar lavages. Mol Cell Probes 1994; 8:273-83.
15. Boivin G, Olson CA, Quirk MR, et al. Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis. J Infect Dis 1996; 173:1304-12.
16. Buffone GJ, Frost A, Samo T, et al. The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation 1993; 56:342-7.
17. Stephan F, Fajac A, Grenet D, et al. Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients. Transplantation 1997; 63:1430-5.
18. Riise GC, Andersson R, Bergstrom T, et al. Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients. Chest 2000; 118:1653-60.
19. Bewig B, Haacke TC, Tiroke A, et al. Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells. Respiration 2000; 67:166-72.
20. Westall GP, Michaelides A, Williams TJ, et al. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 2004; 190:1076-83.
21. Chemaly RF, Yen-Lieberman B, Castilla EA, et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 2004; 42:2168-72.
22. Chemaly RF, Yen-Lieberman B, Chapman J, et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005; 5:544-8.
23. Wiita AP, Roubinian N, Khan Y, et al. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis 2012; 14:248-58.
24. Schlischewsky E, Fuehner T, Warnecke G, et al. Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients. Transpl Infect Dis 2013; 15:60-9.
25. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-7.
26. Waggoner JJ, Pinsky BA. Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues. PeerJ 2014; 2: e334.
27. DiMaio MA, Sahoo MK, Waggoner J, Pinsky BA. Comparison of Xpert Flu rapid nucleic acid testing with rapid antigen testing for the diagnosis of influenza A and B. J Virol Methods 2012; 186:137-40.
28. Ison MG, Fishman JA. Cytomegalovirus pneumonia in transplant recipients. Clin Chest Med 2005; 26:691-705, viii.
29. Kunihiro Y, Tanaka N, Matsumoto T, et al. The usefulness of a diagnostic method combining high-resolution CT findings and serum markers for cytomegalovirus pneumonia and pneumocystis pneumonia in non-AIDS patients. Acta Radiol 2015; 56:806-13.
30. Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010; 152:761-9.
31. Tamm M, Traenkle P, Grilli B, et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest 2001; 119:838-43.
32. Hirsch HH, Lautenschlager I, Pinsky BA, et al. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013; 56:367-73.
33. Pritt BS, Germer JJ, Gomez-Urena E, et al. Conversion to the COBAS AmpliPrep/ COBAS TaqMan CMV Test for management of CMV disease in transplant recipients. Diagn Microbiol Infect Dis 2013; 75:440-2.
34. Babady NE, Cheng C, Cumberbatch E, et al. Monitoring of cytomegalovirus viral loads by two molecular assays in whole-blood and plasma samples from hematopoietic stem cell transplant recipients. J Clin Microbiol 2015; 53:1252-7.
35. Waggoner J, Ho DY, Libiran P, Pinsky BA. Clinical significance of low cytomegalovirus DNA levels in human plasma. J Clin Microbiol 2012; 50:2378-83.
36. Rutjes A, Reitsma JB, Coomarasamy A, et al. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess 2007; 11: ix-51.